This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignee: Exosome Diagnostics, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Wayne Comper: Innovator in Nucleic Acid Extraction Technologies
Introduction
Wayne Comper is a notable inventor based in New York, NY, who has made significant contributions to the field of nucleic acid extraction. With a total of three patents to his name, Comper's work focuses on improving the methods and technologies used in biological sample analysis.
Latest Patents
Comper's latest patents include innovative methods for isolating microvesicles and extracting nucleic acids from biological samples. One of his inventions features a method and kit for isolating microvesicles or extracting microvesicle nucleic acids using control particles, such as viruses or virus-like particles. These control particles contain nucleic acids that can be detected to assess the accuracy and efficiency of the isolation or extraction processes. Additionally, he has developed methods for extracting high-quality nucleic acids from heterogeneous biological materials, ensuring high yield and integrity for various medical applications.
Career Highlights
Wayne Comper is currently associated with Exosome Diagnostics, Inc., where he continues to advance the field of nucleic acid assays. His work is instrumental in enhancing diagnostic, prognostic, and therapeutic evaluations for various medical conditions.
Collaborations
Comper collaborates with esteemed colleagues, including Johan Karl Olov Skog and Leileata M Russo, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wayne Comper's contributions to nucleic acid extraction technologies highlight his role as a leading inventor in the field. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
